MRNA has room to run. The market has yet to figure out that the confluence of Pfizer's findings on mrna vaccine efficacy w/booster + the Danish press surrounding "society-wide" Omicron infection will push MRNA back to the $400 range. Big day coming.$Moderna, Inc.(MRNA)$
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
2
举报
登录后可参与评论
暂无评论